214 related articles for article (PubMed ID: 3997815)
1. 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells.
Sabina RL; Patterson D; Holmes EW
J Biol Chem; 1985 May; 260(10):6107-14. PubMed ID: 3997815
[TBL] [Abstract][Full Text] [Related]
2. Z-nucleotide accumulation in erythrocytes from Lesch-Nyhan patients.
Sidi Y; Mitchell BS
J Clin Invest; 1985 Dec; 76(6):2416-9. PubMed ID: 4077987
[TBL] [Abstract][Full Text] [Related]
3. Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes.
Vincent MF; Bontemps F; Van den Berghe G
Biochem Pharmacol; 1996 Oct; 52(7):999-1006. PubMed ID: 8831718
[TBL] [Abstract][Full Text] [Related]
4. The enzymatic synthesis of 5-amino-4-imidazolecarboxamide riboside triphosphate (ZTP).
Sabina RL; Holmes EW; Becker MA
Science; 1984 Mar; 223(4641):1193-5. PubMed ID: 6199843
[TBL] [Abstract][Full Text] [Related]
5. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
Gong YF; Srinivas RV; Fridland A
Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
[TBL] [Abstract][Full Text] [Related]
6. ZTP (5-amino 4-imidazole carboxamide riboside 5'-triphosphate): a proposed alarmone for 10-formyl-tetrahydrofolate deficiency.
Bochner BR; Ames BN
Cell; 1982 Jul; 29(3):929-37. PubMed ID: 6185232
[TBL] [Abstract][Full Text] [Related]
7. Role of purine biosynthetic intermediates in response to folate stress in Escherichia coli.
Rohlman CE; Matthews RG
J Bacteriol; 1990 Dec; 172(12):7200-10. PubMed ID: 2254281
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
Vincent MF; Marangos PJ; Gruber HE; Van den Berghe G
Diabetes; 1991 Oct; 40(10):1259-66. PubMed ID: 1657665
[TBL] [Abstract][Full Text] [Related]
9. The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation.
Mazzarino RC; Baresova V; Zikánová M; Duval N; Wilkinson TG; Patterson D; Vacano GN
Mol Genet Metab Rep; 2020 Dec; 25():100642. PubMed ID: 32939338
[TBL] [Abstract][Full Text] [Related]
10. Is ZMP the toxic metabolite in Lesch-Nyhan disease?
López JM
Med Hypotheses; 2008 Nov; 71(5):657-63. PubMed ID: 18710792
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.
Swain JL; Hines JJ; Sabina RL; Harbury OL; Holmes EW
J Clin Invest; 1984 Oct; 74(4):1422-7. PubMed ID: 6480832
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mast cell mediator release by 5-amino-4-imidazolecarboxamide riboside.
Marquardt DL; Gruber HE
Biochem Pharmacol; 1986 Dec; 35(24):4415-21. PubMed ID: 2947580
[TBL] [Abstract][Full Text] [Related]
13. Effect of 5-amino-4-imidazolecarboxamide riboside (AICA-riboside) on the purine nucleotide synthesis and growth of rat kidney cells in culture: study with [15N]aspartate.
Nissim I; Yudkoff M; Nissim I; States B
J Cell Physiol; 1989 Mar; 138(3):536-40. PubMed ID: 2925797
[TBL] [Abstract][Full Text] [Related]
14. Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart.
Zhang L; Frederich M; He H; Balschi JA
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1235-43. PubMed ID: 16258030
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes.
Vincent MF; Bontemps F; Van den Berghe G
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):267-72. PubMed ID: 1531010
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle. Effects on purine nucleotide synthesis.
Sabina RL; Kernstine KH; Boyd RL; Holmes EW; Swain JL
J Biol Chem; 1982 Sep; 257(17):10178-83. PubMed ID: 7107599
[No Abstract] [Full Text] [Related]
17. The rate of cell growth is regulated by purine biosynthesis via ATP production and G(1) to S phase transition.
Kondo M; Yamaoka T; Honda S; Miwa Y; Katashima R; Moritani M; Yoshimoto K; Hayashi Y; Itakura M
J Biochem; 2000 Jul; 128(1):57-64. PubMed ID: 10876158
[TBL] [Abstract][Full Text] [Related]
18. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.
Javaux F; Vincent MF; Wagner DR; van den Berghe G
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):913-9. PubMed ID: 7848293
[TBL] [Abstract][Full Text] [Related]
19. 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.
Garcia-Gil M; Pesi R; Perna S; Allegrini S; Giannecchini M; Camici M; Tozzi MG
Neuroscience; 2003; 117(4):811-20. PubMed ID: 12654334
[TBL] [Abstract][Full Text] [Related]
20. Preparation of 5-amino-4-imidazole-N-succinocarboxamide ribotide, 5-amino-4-imidazole-N-succinocarboxamide riboside and succinyladenosine, compounds usable in diagnosis and research of adenylosuccinate lyase deficiency.
Zikánová M; Krijt J; Hartmannová H; Kmoch S
J Inherit Metab Dis; 2005; 28(4):493-9. PubMed ID: 15902552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
